Clinical Trial Update: Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing long-term effects of Amantadine in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• amantadine (amantadine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED